Skip to main content
Top
Published in: Journal of Nephrology 6/2017

01-12-2017 | Erratum

Erratum to: Ultrapure dialysis water obtained with additional ultrafilter may reduce inflammation in patients on hemodialysis

Authors: Biagio Di Iorio, Lucia Di Micco, Dario Bruzzese, Luca Nardone, Luigi Russo, Pietro Formisano, Vittoria D’Esposito, Domenico Russo

Published in: Journal of Nephrology | Issue 6/2017

Login to get access

Excerpt

In original publication, the Table 4 was incorrect. The correct Table 4 has been given below:
Table 4
Concentrations of hemoglobin, ESA doses and erythropoietin resistance index (ERI) at Control and Study phase
Variable
Number
Control-phase
Study-phase
Percent variation study versus control phase
Hemoglobin (g/dl)
32
11.2 ± 0.9
11.9 ± 1.3
+6.25
Epoietin alpha (units per week)
19
11,313 ± 650
8670 ± 554
−23.4
Darboepoietin alpha (units per week)
10
80 ± 11
61 ± 12+
−23.7
Mircera (unit per month)
3
233 ± 130
152 ± 67
−34.8
ERI: EPO (week/BW)/Hb
29
13.1 ± 7.5
9.5 ± 6.0
 
Numbers are mean ± SD
p < 0.01
+ p < 0.05
Metadata
Title
Erratum to: Ultrapure dialysis water obtained with additional ultrafilter may reduce inflammation in patients on hemodialysis
Authors
Biagio Di Iorio
Lucia Di Micco
Dario Bruzzese
Luca Nardone
Luigi Russo
Pietro Formisano
Vittoria D’Esposito
Domenico Russo
Publication date
01-12-2017
Publisher
Springer International Publishing
Published in
Journal of Nephrology / Issue 6/2017
Print ISSN: 1121-8428
Electronic ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-017-0441-7

Other articles of this Issue 6/2017

Journal of Nephrology 6/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.